<html>
<head>PUBMED IDs for SCG3</head>
<body bgcolor='#C5F0F2'><h1>SCG3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/17200173/'>Functional single-nucleotide polymorphisms in the secretogranin III (SCG3) gene that form secretory granules with appetite-related neuropeptides are associated with obesity.</a> January 4  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19202896/'>[New insights about obesity-related genes].</a> April 22  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19357184/'>Secretogranin II binds to secretogranin III and forms secretory granules with orexin, neuropeptide Y, and POMC.</a> July 23  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21796137/'>Association of variations in the FTO, SCG3 and MTMR9 genes with metabolic syndrome in a Japanese population.</a> March 10  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21853033/'>Gene network inference and biochemical assessment delineates GPCR pathways and CREB targets in small intestinal neuroendocrine neoplasia.</a> December 20  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23091610/'>Integrative analysis of somatic mutations altering microRNA targeting in cancer genomes.</a> March 30  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24882622/'>The oncoprotein HBXIP up-regulates SCG3 through modulating E2F1 and miR-509-3p in hepatoma cells.</a> October 10  2014<br></body></html>
